Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Introduction</h3><p>The coronavirus disease (COVID‐19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which play important roles in regulating gene expression and are also considered as essential modulators during viral infection. The aim of this study was to elucidate the differential expression of miRNAs in COVID‐19.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>The total RNA was extracted and purified from the peripheral blood of ten patients with COVID‐19 and four healthy donors. The expression levels of various miRNAs were detected by high‐throughput sequencing, and correlation analysis was performed on the target genes that are primed by miRNAs.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Key findings</h3><p>Compared with the healthy controls, 35 miRNAs were upregulated and 38 miRNAs were downregulated in the human patients with COVID‐19. The top 10 genes were listed below: hsa‐miR‐16‐2‐3P,hsa‐miR‐5695,hsa‐miR‐10399‐3P,hsa‐miR‐6501‐5P,hsa‐miR‐361‐3P,hsa‐miR‐361‐3p, hsa‐miR‐4659a‐3p, hsa‐miR‐142‐5p, hsa‐miR‐4685‐3p, hsa‐miR‐454‐5p, and hsa‐miR‐30c‐5p. The 10 genes with the greatest reduction were listed below: hsa‐miR‐183‐5p, hsa‐miR‐627‐5p, hsa‐miR‐941, hsa‐miR‐21‐5p, hsa‐miR‐20a‐5p, hsa‐miR‐146b‐5p, hsa‐miR‐454‐3p, hsa‐miR‐18a‐5p, hsa‐miR‐340‐5p, and hsa‐miR‐17‐5p. Remarkably, miR‐16‐2‐3p was the most upregulated miRNA, with a 1.6‐fold change compared to that of the controls. Moreover, the expression of miR‐6501‐5p and miR‐618 was 1.5‐fold higher in the COVID‐19 patients than in the healthy donors. Meanwhile, miR‐627‐5p was the most downregulated miRNA, with a 2.3‐fold change compared to that of the controls. The expression of other miRNAs (miR‐183‐5p, miR‐627‐5p, and miR‐144‐3p) was reduced by more than 1.3‐fold compared to that of the healthy donors. Cluster analysis revealed that all of the differentially expressed miRNA target genes were clustered by their regulation of cellular components, molecular functions, and biological processes. Importantly, peptidases, protein kinases, and the ubiquitin system were shown to be the highest enrichment categories by enrichment analysis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>The differential miRNA expression found in COVID‐19 patients may regulate the immune responses and viral replication during viral infection.</p></section>

Expression Profiles of Plasma IFN Signaling-Related miRNAs (ISR-miRNAs) at the Acute and Recovery Phase of COVID-19

Expression of Plasma IFN Signaling-Related Mirnas During Acute SARS-CoV-2 Infection and Its Association with RBD-IgG Antibody Response

Overly Exuberant Innate Immune Response to SARS-CoV-2 Infection

Circulating miRNAs in the Plasma of Post-COVID-19 Patients with Typical Recovery and Those with Long-COVID Symptoms: Regulation of Immune Response-Associated Pathways

Inflammation and Antiviral Immune Response Associated With Severe Progression of COVID-19

Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

Interferon response and profiling of interferon response genes in peripheral blood of vaccine-naive COVID-19 patients

Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing

Plasma miRNA profile at COVID-19 onset predicts severity status and mortality

Plasma cell-free RNA characteristics in COVID-19 patients

Differential microRNA expression in the peripheral blood from human patients with COVID‐19

Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity

Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients

Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19

Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease

Serum Levels of Type I Interferon (IFN-I) is Associated with the Severity of COVID-19.

Distinct miRNAs associated with various clinical presentations of SARS-CoV-2 infection

Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection

Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome

Profiling of the immune repertoire in COVID-19 patients with mild, severe, convalescent, or retesting-positive status

Dynamic blood single-cell immune responses in patients with COVID-19